Posted at 4:44 p.m., Thursday, November 8, 2007
Tissue Genesis signs licensing deal with SpineSmith
Advertiser Staff
Honolulu-based Tissue Genesis Inc. today said it signed a distribution and licensing agreement with SpineSmith Partners LP.Austin, Texas-based SpineSmith will market Tissue Genesis' therapeutic cell technologies for the human spine market. Tissue Genesis will share SpineSmith's revenues from procedures and sales and expects to receive revenue from sales to SpineSmith. SpineSmith has been granted rights to manufacture, use and sell Tissue Genesis manual cell isolation kits.
"This exciting new relationship with SpineSmith allows Tissue Genesis to move our therapeutic cell technologies into orthopedic markets," said Anton Krucky, president and chief executive for Tissue Genesis. "SpineSmith's extensive expertise with bone marrow stem cells, in both cell isolation and medical insurance reimbursement, provides a clear avenue of advancement of our adipose (fat) derived stem cells into this important market."
